PIL
04/11/2015 11:02
GENERAL
PRICE SENSITIVE
REL: 1102 HRS Promisia Integrative Limited
GENERAL: PIL: Sales of Arthrem(R) increase by over 170%
Chairman of Promisia Integrative Limited , Malcolm Johnson, announced today a
170% increase in sales of Arthrem(R) in the 5 months to 31 October 2015
compared with the same 5 months in the previous year. This significant
increase in sales has occurred since the company announced, in May 2015, the
results of its clinical trial and increased its advertising expenditure.
The Company's Chief Executive Charles Daily said: "As stated in previous
announcements, we believe this is just the beginning of accelerated sales
growth. When you combine a clinically proven product with an effective
advertising campaign you are going to get increased sales."
Arthrem(R) is a dietary supplement for the long-term management of symptoms
associated with osteoarthritis. Worldwide, osteoarthritis affects
approximately 14% of adults aged over 25 years and 34% of adults aged over 65
years.
For further information please contact:
Charles Daily, Chief Executive on (04) 894 8524 or
Malcolm Johnson, Chairman on (04) 479 3377
ENDS
End CA:00272822 For:PIL Type:GENERAL Time:2015-11-04 11:02:17